ESMO Symposium on Signalling Pathways in Cancer 2019: Industry Participation

The 7th edition of the ESMO Symposium on Signalling Pathways 2019 is organised by leading professionals in the field, with objective to provide education and in-depth updates on the latest scientific developments on a personalised approach to cancer treatment.

Main Theme: Gene fusions - From gene architecture evolution to cell addiction and therapeutic opportunities.

All companies with an interest in this theme are encouraged both to support this event and actively participate in the scientific programme.

The 7th edition of ESMO Symposium on Signalling Pathways 2019 is in partnership with the European Association for Cancer Research (EACR).

Fast Facts: ESMO Symposium on Signalling Pathways 2019

  • No parallel sessions
  • Interactive Q&A time after each educational session
  • Possibility to host a satellite symposium
  • An internationally renowned faculty
  • Excellent networking event for Industry

Italian Agency (AIFA applications)

The appointed agency to collect on ESMO behalf all applications from the Pharmaceutical Companies and file them with AIFA (Italian Drug Agency) is:

AIM Group International – AIM Education S.r.l.
Via G. Ripamonti, 129
20141 Milan, Italy

Contact: Valentina Disabato / Cristina Ghidoli

How can I participate in the ESMO Symposium on Signalling Pathways?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.

Contact the ESMO Strategic Partnerships Team for more details. We look forward to hearing from you!

Preparatory Information

To get up to speed with your preparation for ESMO Symposium on Signalling Pathways 2019, please download our Industry Guidelines below.